Bayview Physicians Group ACO

ACO Name and Location:

Bayview Physician Services, PC
Previous Names: N/A
3241 Western Branch Blvd.
Chesapeake, Virginia 23321

ACO Primary Contact:

Primary Contact Name:
Primary Contact Phone Number:
Primary Contact Email Address:

Mrs. Heather Lendi
757-686-3508
milteer@msaphy.com

Organizational Information:

Bayview Physicians Services, PC ACO Participants

ACO ParticipantsACO Participant in Joint Venture (Y or N)
Bayview Physicians Services, PCY

ACO Governing Body:

Last NameFirst NameTitle/PositionMember’s Voting PowerMembership TypeACO Participant Legal Business Name
CentroneAnthonyChair9.09%ACO Participant RepresentativeBayview Physicians Services, PC
HartzJamesVice Chair18.18%ACO Participant RepresentativeBayview Physicians Services, PC
FormanJeffreyVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
HutchinsonAnneVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
StockmanLynneVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
SposatoJosephVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
ArusiEliVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
OliverSandraVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
LendiHeatherVoting Member9.09%ACO Participant RepresentativeBayview Physicians Services, PC
McNamaraJackVoting Member9.09%Medicare Beneficiary RepresentativeBayview Physicians Services, PC

Key ACO Clinical and Administrative Leadership:

ACO Executive
Medical Director
Compliance Officer
Quality Assurance/Improvement Officer

James Hartz
Jeffrey Forman
Sandra Oliver
Heather Lendi

Associated Committees and Committee Leaderships:

Committee Name
Quality Committee
Compliance Committee
Finance Committee

Committee Leader Name & Position
Dr. Jeffrey Forman, Chair
Sandra Oliver, Chair
James Hartz, Chair

Types of ACO Participants or Combinations of Participants that Formed the ACO:

  • ACO professionals in a group practice arrangement

Shared Savings and Losses:

Amount of Shared Savings/Losses:

  • Second Agreement Period
    • Performance Year 2020, $1,005,375
    • Performance Year 2019, $2,293,958
    • Performance Year 2018, $1,478,899
    • Performance Year 2017, $0
  • ​First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 70%
      • Proportion invested in redesigned care processes/resources: 30%
      • Proportion of distribution to ACO participants: 0%
    • Performance Year 2019
      • Proportion invested in infrastructure: 70%
      • Proportion invested in redesigned care processes/resources: 30%
      • Proportion of distribution to ACO participants: 0%
    • Performance Year 2018
      • Proportion invested in infrastructure: 70%
      • Proportion invested in redesigned care processes/resources: 30%
      • Proportion of distribution to ACO participants: 0%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 Quality Performance Results:

ACO #Measure NameRateACO Mean
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))0.820.95
ACO-13Falls: Screening for Future Fall Risk93.5184.97
ACO-14Preventive Care and Screening: Influenza Immunization70.0876.03
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention82.0581.67
ACO-18Preventive Care and Screening: Screening for Depression and Follow-up Plan87.5271.46
ACO-19Colorectal Cancer Screening76.6272.59
ACO-20Breast Cancer Screening74.3174.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease83.3183.37
ACO-27Diabetes: Hemoglobin A1c Poor Control (>9%)12.3214.7
ACO-28Controlling High Blood Pressure73.972.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For previous year’s Financial and Quality Performance Results, please visit data.cms.gov.